Dr. Lori J Wirth, MD

Claim this profile

Massachusetts General Hospital

Studies Medullary Thyroid Cancer
Studies Papillary Thyroid Cancer
4 reported clinical trials
7 drugs studied

Area of expertise

1

Medullary Thyroid Cancer

Lori J Wirth, MD has run 4 trials for Medullary Thyroid Cancer. Some of their research focus areas include:

RET positive
Stage IV
Stage III
2

Papillary Thyroid Cancer

Lori J Wirth, MD has run 3 trials for Papillary Thyroid Cancer. Some of their research focus areas include:

RET positive
Stage IV
Stage III

Affiliated Hospitals

Image of trial facility.

Massachusetts General Hospital

Clinical Trials Lori J Wirth, MD is currently running

More about Lori J Wirth, MD

Clinical Trial Related

5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Lori J Wirth, MD has experience with

  • Selpercatinib
  • RhTSH
  • Sodium Iodine I-131
  • LOXO-292
  • Cabozantinib
  • Vandetanib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Lori J Wirth, MD specialize in?

Is Lori J Wirth, MD currently recruiting for clinical trials?

Are there any treatments that Lori J Wirth, MD has studied deeply?

What is the best way to schedule an appointment with Lori J Wirth, MD?

What is the office address of Lori J Wirth, MD?

Is there any support for travel costs?